Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHACRY-1501
2024-513078-23-00Phase 2Authorised
- Sponsor
- Centre Oscar Lambret
- Start
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of follitropin alfa and follitropin beta in breast cancer (2 arms), sponsored by Centre Oscar Lambret. Planned start Jun 2024; status: authorised.
02
Drugs
follitropin alfafollitropin beta
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2024-513078-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513078-23-00.